# Combination Chemotherapy and Cyclosporine Followed by Focal Therapy for Bilateral Retinoblastoma

> **NCT00110110** · PHASE2 · UNKNOWN · sponsor: **The Hospital for Sick Children** · enrollment: 71 (estimated)

## Conditions studied

- Retinoblastoma

## Interventions

- **BIOLOGICAL:** filgrastim
- **DRUG:** Carboplatin
- **DRUG:** Cyclosporine
- **DRUG:** Etoposide
- **DRUG:** vincristine sulfate
- **PROCEDURE:** cryosurgery
- **PROCEDURE:** laser therapy

## Key facts

- **NCT ID:** NCT00110110
- **Lead sponsor:** The Hospital for Sick Children
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2004-06
- **Primary completion:** 2016-04-20
- **Final completion:** 2024-12-31
- **Target enrollment:** 71 (ESTIMATED)
- **Last updated:** 2024-04-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00110110

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00110110, "Combination Chemotherapy and Cyclosporine Followed by Focal Therapy for Bilateral Retinoblastoma". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT00110110. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*